Industry Focus
Healthcare: This Drug Pricing Scheme Could Be Making Your Medicine More Expensive
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:25:56
- Mas informaciones
Informações:
Sinopsis
Unpacking Axovant Sciences big Alzheimer’s disease disappointment, plus Pfizer accuses Johnson & Johnson of unfairly increasing healthcare costs.
